The 0madacycline Tablet, cataloged under National Stock Number 6505-01-685-8977, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Paratek Pharmaceuticals, Inc Div Paratek Pharma. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-685-8977 |
| Primary Part Number | NDC71715-0002-23 |
| Item Name | 0madacycline Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Paratek Pharmaceuticals, Inc Div Paratek Pharma |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC71715-0002-23 PRIMARY | Paratek Pharmaceuticals, Inc Div Paratek Pharma (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM205893 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1566614 | 5/1 Secondary reference U.S. Government activity |
| NUZYRA | 5/1 Secondary reference Paratek Pharmaceuticals, Inc Div Paratek Pharma |
NSN 6505-01-685-8977 is a 0madacycline Tablet, manufactured by Paratek Pharmaceuticals, Inc Div Paratek Pharma, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-685-8977 has 1 manufacturer part number on file: NDC71715-0002-23 (Paratek Pharmaceuticals, Inc Div Paratek Pharma).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-687-0837. Verify interchangeability with system specifications before substitution.
Key specifications for NDC71715-0002-23: Special Features: A TETRACYCLINE CLASS ANTIBACTERIAL INDICATED FOR THE TREATMENT OF ADULT PATIENTS WITH INFECTIONS CAUSED BY SUSCEPTIBLE MICROORGANISMS; EACH TABLET CONTAINS 150MG OF OMADACYCLINE(EQUIVALENT TO 196MG OMADACYCLINE TOSYLATE) IN YELLOW DIAMOND SHAPED, FILM-COATED TABLETS DEBOSSED WITH OMC ON ONE SIDE AND 150 ON THE OTHER SIDE; UNIT DOSE BLISTER PACKAGE OF 14; SHOULD BE STORED AT 20C TO 25C(68F TO 77F); EXCURSIONS PERMITTED TO 15C TO 30C(59F TO 86F) SEE USP CONTROLLED ROOM TEMPERATURE; DO NOT FREEZE; 7 DAYS ORAL PACK.; Part Name Assigned by Controlling Agency: OMADACYCLINE TABLETS, 150 MG, 14S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.